Research graph
References from Molecular Mimicry of SARS-CoV-2 Spike Protein in the Nervous System: A Bioinformatics Approach. Local targets link to admitted publications; unresolved targets remain external evidence.
Neurological complications of coronavirus and COVID-19
10.33588/rn.7009.2020179 · 2020 · External reference
10.1001/jamaneurol.2020.1127
10.1001/jamaneurol.2020.1127 · External reference
Neurological complications of COVID-19 and possible neuroinvasion pathways: a systematic review
10.3390/ijerph17186688 · 2020 · External reference
10.1002/acn3.51166
10.1002/acn3.51166 · External reference
Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases
10.1186/s12974-021-02293-x · 2021 · External reference
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
2021 · External reference
10.1080/20009666.2021.1954284
10.1080/20009666.2021.1954284 · External reference
Guillain-Barré syndrome after COVID-19 vaccination
10.1136/bcr-2021-244125 · 2021 · External reference
10.1093/nar/gkaa1074
10.1093/nar/gkaa1074 · External reference
Network-based bioinformatics approach to identify molecular biomarkers for type 2 diabetes that are linked to the progression of neurological diseases
10.3390/ijerph17031035 · 2020 · External reference
Gene Ontology annotations: what they mean and where they come from
2008 · External reference
Unresolved reference
External reference
Protein homology detection by HMM-HMM comparison
10.1093/bioinformatics/bti125 · 2005 · External reference
10.1093/nar/gkaa379
10.1093/nar/gkaa379 · External reference
10.1186/1471-2172-9-1
10.1186/1471-2172-9-1 · External reference
Proteome profile of peripheral myelin in healthy mice and in a neuropathy model
2020 · External reference
The CNS myelin proteome: deep profile and persistence after post-mortem delay
10.3389/fncel.2020.00239 · 2020 · External reference
10.1111/j.1471-4159.2006.04319.x
10.1111/j.1471-4159.2006.04319.x · External reference
10.1016/s0140-6736(21)00517-1
10.1016/s0140-6736(21)00517-1 · External reference
Enhanced susceptibility to cytotoxic T lymphocytes of target cells isolated from virus-infected or interferon-treated mice
10.1128/jvi.59.3.735-739.1986 · 1986 · External reference
10.1111/j.0105-2896.2010.00897.x
10.1111/j.0105-2896.2010.00897.x · External reference
10.1038/nri3279
10.1038/nri3279 · External reference
10.1002/psc.2419
10.1002/psc.2419 · External reference
10.1371/journal.pone.0001831
10.1371/journal.pone.0001831 · External reference
10.1016/j.xcrm.2021.100204
10.1016/j.xcrm.2021.100204 · External reference
10.3390/antib7010002
10.3390/antib7010002 · External reference
Myelin biogenesis: sorting out protein trafficking
10.1016/j.cub.2006.05.010 · 2006 · External reference
10.1126/sciadv.1700220
10.1126/sciadv.1700220 · External reference
Unresolved reference
External reference
10.1615/critrevimmunol.v32.i4.50
10.1615/critrevimmunol.v32.i4.50 · External reference
10.1038/ni835
10.1038/ni835 · External reference
On the molecular determinants of the SARS-CoV-2 attack
10.1016/j.clim.2020.108426 · 2020 · External reference
10.1038/nrmicro1709
10.1038/nrmicro1709 · External reference
10.1016/j.clim.2007.02.002
10.1016/j.clim.2007.02.002 · External reference
10.1038/sj.emboj.7600771
10.1038/sj.emboj.7600771 · External reference
10.1038/s41590-020-00808-x
10.1038/s41590-020-00808-x · External reference
Autoimmune disorders of the nervous system: pathophysiology, clinical features, and therapy
10.3389/fneur.2021.664664 · 2021 · External reference
HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection
2021 · External reference
The MHC locus and genetic susceptibility to autoimmune and infectious diseases
10.1186/s13059-017-1207-1 · 2017 · External reference
10.1038/nrneurol.2014.260
10.1038/nrneurol.2014.260 · External reference
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
10.1016/j.clim.2020.108480 · 2020 · External reference
Binding specificity of anti-HNK-1 IgM M-protein in anti-MAG neuropathy: possible clinical relevance
10.1016/j.neures.2014.09.010 · 2015 · External reference
Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases
10.3389/fimmu.2020.617089 · 2021 · External reference
10.1007/s12026-020-09152-6
10.1007/s12026-020-09152-6 · External reference
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders [Internet]
10.1038/nrneurol.2014.260 · 2015 · External reference
10.1152/physrev.00033.2013
10.1152/physrev.00033.2013 · External reference
10.1007/s13311-015-0402-6
10.1007/s13311-015-0402-6 · External reference
Anti-MAG IgM: differences in antibody tests and correlation with clinical findings
10.1007/s10072-019-04089-7 · 2020 · External reference
Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy
10.1016/j.jneuroim.2019.577127 · 2020 · External reference
10.1126/science.1260419
10.1126/science.1260419 · External reference
Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies
10.1007/s00415-019-09367-0 · 2019 · External reference
10.1016/j.bbrc.2019.12.002
10.1016/j.bbrc.2019.12.002 · External reference
10.1007/s10048-017-0515-7
10.1007/s10048-017-0515-7 · External reference
10.1016/j.neurobiolaging.2006.06.014
10.1016/j.neurobiolaging.2006.06.014 · External reference
Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke
10.1136/jnnp-2020-323522 · 2020 · External reference
The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens
2020 · External reference
10.1038/s41586-020-2550-z
10.1038/s41586-020-2550-z · External reference
10.3390/cells11010067
10.3390/cells11010067 · External reference
Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies
2021 · External reference
